When will nucynta go generic?

Nucynta (tapentadol) is an opioid analgesic. I don’t have live access to current regulatory databases, but here’s how to think about “when it goes generic”:

• Generic availability usually depends on patent/market-exclusivity expiration for the specific formulation(s) (e.g., Nucynta immediate‑release vs Nucynta ER extended‑release) and the country (U.S. vs other markets).
• In the U.S., many tapentadol generics have tended to appear after the relevant exclusivity/patents expire and once ANDA approvals are granted—so availability can lag a bit behind the patent date.

If you tell me:

1. whether you mean Nucynta IR or Nucynta ER, and
2. your country (U.S., Canada, UK, etc.),

…I can give you a much more precise answer (and point to the typical patent/exclusivity milestones that determine the timeline).